This study aimed to investigate the potential molecular mechanisms underlying the immune escape of triple-negative breast cancer (TNBC) through the interaction between tumor stem cell-like cells and immune cells, mediated by the CHI3L1/MAF/CTLA4 signaling pathway, using single-cell transcriptomic sequencing technology. This evidence concerns the gene CTLA4 and triple-negative breast carcinoma.